{"schema_version":"secwatch.filing_event.v1","accession":"0001944048-24-000007","form_type":"8-K","ticker":"KVUE","cik":"0001944048","company_name":"Kenvue Inc.","filed_at":"2024-02-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.353141+00:00","generated_at":"2026-06-06T05:57:19.418664+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Kenvue reports FY23 revenue $15.4B (+3.3%); Q4 revenue down 2.7%; guides FY24 adjusted EPS $1.10-1.20","bullets":["FY23 net sales $15.4B, +3.3%; organic growth 5.0%; adjusted diluted EPS $1.29.","Q4 net sales $3.7B, -2.7%; organic decline 2.4%; adjusted EPS $0.31.","FY23 diluted EPS $0.90 (GAAP); adjusted $1.29.","FY24 outlook: net sales growth 1-3%, organic 2-4%; adjusted EPS $1.10-$1.20, below FY23.","CEO cites U.S. Skin Health/Beauty weakness; expects sequential improvement in 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001944048-24-000007","json":"https://secwatch.observer/filing/0001944048-24-000007.json","markdown":"https://secwatch.observer/filing/0001944048-24-000007.md","text":"https://secwatch.observer/filing/0001944048-24-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1944048/000194404824000007/0001944048-24-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1944048/000194404824000007/kvue-20240208.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T05:57:19.418664+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"05c655ce8fbca637d8e7b1156ef89ae0079d6f7f","claim":"Kenvue Inc. reported the fiscal full year and fourth quarter ended December 31, 2023 results: revenue $15.4 billion, EPS $0.90. Guidance initiated.","evidence_excerpt":"Kenvue Reports Full Year and Fourth Quarter 2023 Results FY'23: Net Sales Increased 3.3% to $15.4 billion with Organic Growth 1 of 5.0% FY'23: Diluted Earnings per Share of $0.90; Adjusted Diluted Earnings per Share 1 of $1.29 Q4'23: Net Sales Decreased (2.7)% to $3.7 billion with Organic Growth 1 of (2.4)% Q4'23: Diluted Earnings per Share of $0.17; Adjusted Diluted Earnings per Share 1 of $0.31","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1944048/000194404824000007/0001944048-24-000007-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal full year and fourth quarter ended December 31, 2023"},{"label":"Revenue","value":"$15.4 billion"},{"label":"EPS","value":"$0.90"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}